To characterize cardiac physiology in pregnant women with pulmonary hypertension (pHTN) and to compare these measurements when taken during the remote postpartum period (> 12 weeks). STUDY DESIGN: Pregnant women with pHTN who delivered within our healthcare system from 2011 to 2017 were studied. pHTN was diagnosed when the pulmonary artery systolic pressure exceeded 25 mmHg as estimated by right ventricular systolic pressure (RVSP) on echocardiography or measured directly by mean pulmonary artery pressure (PAPm) on right heart catheterization (RHC). Primary outcomes included comparison of pregnant versus remote postpartum measurements of pulmonary artery pressure (PAP), leftventricular ejection fraction (LVEF), left-ventricular mass index (LVMi), and relative wall thickness (RWT). Statistical analyses performed included Pearson correlation coefficient and student's t-test. RESULTS: A total of 41 pregnancies with pHTN in 36 women were identified, and there were 18 pregnancies in which these studies were performed again > 12 weeks postpartum. As shown in Figure 1 , pulmonary artery pressures determined during pregnancy versus remote postpartum were not significantly different (50.9 AE 18.6 mmHg and 46.1 AE 19.7 mmHg, p¼0.18). LVEF, LVMi, and RWT were also not significantly different between these two time points (Table 1 ). In the 14 women in whom both an initial RVSP and PAPm in pregnancy were performed, RVSP was found to overestimate directly measured pulmonary artery pressure (54.1AE20.4 versus 33.9 AE10.2 mm Hg, p ¼ 0.0004). CONCLUSION: These data allow us to make at least three observations: (1) Pulmonary artery pressure does not appreciably change during pregnancy compared with pressure in the remote postpartum period. Thus, the long-term need for follow-up should be emphasized even when mild, asymptomatic pHTN is diagnosed. (2) Woman with pHTN do not show evidence of change in left ventricular mass index or relative wall thickness when measurements in pregnancy are compared with those in the remote postpartum period. Thus, cardiac remodeling in these women is different from that of normally pregnant women. (3) Echocardiography in pregnancy overestimates PAPm compared with direct measurement by RHC. This confirms observations of others that RHC measurements should be used for major management decisions.
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To characterize cardiac physiology in pregnant women with pulmonary hypertension (pHTN) and to compare these measurements when taken during the remote postpartum period (> 12 weeks). STUDY DESIGN: Pregnant women with pHTN who delivered within our healthcare system from 2011 to 2017 were studied. pHTN was diagnosed when the pulmonary artery systolic pressure exceeded 25 mmHg as estimated by right ventricular systolic pressure (RVSP) on echocardiography or measured directly by mean pulmonary artery pressure (PAPm) on right heart catheterization (RHC). Primary outcomes included comparison of pregnant versus remote postpartum measurements of pulmonary artery pressure (PAP), leftventricular ejection fraction (LVEF), left-ventricular mass index (LVMi), and relative wall thickness (RWT). Statistical analyses performed included Pearson correlation coefficient and student's t-test. RESULTS: A total of 41 pregnancies with pHTN in 36 women were identified, and there were 18 pregnancies in which these studies were performed again > 12 weeks postpartum. As shown in Figure 1 , pulmonary artery pressures determined during pregnancy versus remote postpartum were not significantly different (50.9 AE 18.6 mmHg and 46.1 AE 19.7 mmHg, p¼0.18). LVEF, LVMi, and RWT were also not significantly different between these two time points (Table 1 ). In the 14 women in whom both an initial RVSP and PAPm in pregnancy were performed, RVSP was found to overestimate directly measured pulmonary artery pressure (54.1AE20.4 versus 33.9 AE10.2 mm Hg, p ¼ 0.0004). CONCLUSION: These data allow us to make at least three observations: (1) Pulmonary artery pressure does not appreciably change during pregnancy compared with pressure in the remote postpartum period. Thus, the long-term need for follow-up should be emphasized even when mild, asymptomatic pHTN is diagnosed. (2) Woman with pHTN do not show evidence of change in left ventricular mass index or relative wall thickness when measurements in pregnancy are compared with those in the remote postpartum period. Thus, cardiac remodeling in these women is different from that of normally pregnant women. (3) Echocardiography in pregnancy overestimates PAPm compared with direct measurement by RHC. This confirms observations of others that RHC measurements should be used for major management decisions. OBJECTIVE: There are ongoing barriers to perinatal mental health treatment that translate to disparities in outcomes. Perinatal collaborative care is a health services model designed to improve mental illness identification and treatment in the obstetric setting. While perinatal collaborative care improves mental health outcomes in randomized trials, not all referred women engage in care during implementation, and this could contribute to ongoing disparities. Our objective was to identify patient characteristics and expressed reasons for lack of patient engagement during implementation of a perinatal collaborative care program. STUDY DESIGN: This retrospective cohort included all women referred by their obstetrician to a large perinatal collaborative care program between January 2017 and July 2018 due to concern for a mental illness. Women were dichotomized by engagement in collaborative care services based on whether they completed initial psychosocial screenings and received mental health treatment and/or monitoring. Sociodemographic, obstetric, and psychiatric characteristics of women were abstracted from the medical record and compared across engagement status in bivariable analyses. Reasons for nonengagement were systematically assessed by the collaborative care coordinator. RESULTS: Of the 663 eligible women, 498 (75.1%) engaged in the collaborative care program. Compared with women who engaged in collaborative care services, women who did not engage were younger and more likely to self-identify as a racial/ethnic minority, have transferred obstetric care antenatally, and have an incident mental health diagnosis (Table) . The most commonly reported reason for non-enrollment was denial of medical necessity of psychiatric care (46.1%) (Figure) . CONCLUSION: The identified characteristics of women less likely to engage in collaborative care could allow for targeted outreach and focused intervention efforts aimed at mitigating disparities in perinatal mental health outcomes. As the perception that mental health care was not medically necessary was a common reason for nonengagement, future research should assess ongoing psychoeducation as a means of improving engagement of women referred to collaborative care. 
We sought to determine the differences in pregnancy outcomes in patients with pre-existing major depressive disorder compared to unaffected women. STUDY DESIGN: A retrospective cohort study comparing the rate of neonatal outcomes among singleton, non-anomalous births in California to women with or without the diagnosis of depression between 2007 and 2011. Neonatal outcomes of interest included preterm delivery (divided into <37, <34 and <32 weeks gestational age), respiratory distress syndrome (RDS), neonatal jaundice, neonatal hypoglycemia, neonatal seizures, and neonatal death (NND). Multivariate regression analyses and chi-square tests were employed for statistical comparisons and a p-value of less than 0.05 was used to indicate statistical significance. RESULTS: Of the 2,214,533 births in California, 18,775 (0.85%) women were diagnosed with depression. Depression was significantly associated with an increased risk of neonatal morbidity and mortality, including preterm delivery at <37, <34, and <32 weeks gestational age (Adjusted Odds Ratio [aOR] 1.33, 95% CI 1.27-1.39; 1.43, 95% CI 1.34-1.52; 1.27, 95% CI 1.17-1.38 respectively), RDS (aOR 1.38, 95% CI 1.27-1.49), neonatal seizures (aOR 2.69, 95% CI 1.89-3.81), jaundice (aOR 1.16, 95% CI 1.12-1.20), hypoglycemia (aOR 1.39, 95% CI 1.21-1.59), and NND (aOR 1.66, 1.14-2.42) (Table 1, Figure 1) . CONCLUSION: Women with depression are at increased risk for adverse neonatal outcomes in pregnancy. The influence of pharmacologic and behavioral based interventions on these outcomes need to be explored.
